Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetics and Indian Ministry Wants To Cancel Patent on Trastuzumab under section 66 of the Indian Patent Act
This document provides an overview of patents related to breast cancer, with a focus on gene therapy patents and legal developments in the US and India. It summarizes Myriad Genetics' patents on the breast cancer genes BRCA1 and BRCA2, the US Supreme Court case that invalidated patents on isolated genomic DNA, and ongoing debates around patenting genes and healthcare costs. The document also reviews India's consideration of revoking patents on the breast cancer drug Trastuzumab to lower treatment costs and increase access.
Genome in a Bottle- reference materials to benchmark challenging variants and...
Similar to Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetics and Indian Ministry Wants To Cancel Patent on Trastuzumab under section 66 of the Indian Patent Act
Similar to Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetics and Indian Ministry Wants To Cancel Patent on Trastuzumab under section 66 of the Indian Patent Act (20)
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Breast Cancer and Gene therapy Patent Landscape: Discussion on Myriad Genetics and Indian Ministry Wants To Cancel Patent on Trastuzumab under section 66 of the Indian Patent Act